← Human Trials & Peer-Reviewed Studies
Exercise and glycemic imbalances: a situation-specific estimate of glucose supplement.
Plain-language guide to PMID 20473219 (2011): clinical trial of Glucose and Insulin.
Key Facts
- PMID
- 20473219
- Journal
- Medicine and science in sports and exercise
- Year
- 2011
- Study type
- Clinical Trial
- Authors
- Francescato MP et al. (6 authors)
- DOI
- 10.1249/MSS.0b013e3181e6d6a1
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Glucose and Insulin, published as a clinical trial.
The purposes of this study were to describe a newly developed algorithm that estimates the glucose supplement on a patient- and situation-specific basis and to test whether these amounts would be appropriate for maintaining blood glucose levels within the recommended range in exercising type 1 diabetic patients.
Who Took Part
The age groups tagged for this paper are adults and middle-aged adults, both men and women.
The algorithm first estimates the overall amount of glucose oxidized during exercise on the basis of the patient's physical fitness, exercise intensity, and duration.
The amount of supplemental CHO to be consumed before or during the effort represents a fraction of the burned quantity depending on the patient's usual therapy and insulin sensitivity and on the time of day the exercise is performed.
How the Study Was Run
The algorithm was tested in 27 patients by comparing the estimated amounts of supplemental CHO with the actual amounts required to complete 1-h constant-intensity walks.
Each patient performed three trials, each of which started at different time intervals after insulin injection (81 walks were performed overall).
Glycemia was tested every 15 min.
What Was Measured
PubMed files the paper under topics including Algorithms, Blood Glucose, Decision Support Techniques, Diabetes Mellitus, Type 1, Dietary Supplements, Exercise and Glucose.
What This Means in Plain Language
This is a clinical trial of Glucose and Insulin.
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2011 (Medicine and science in sports and exercise), a journal based in United States.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.